These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16469942)

  • 1. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.
    Potter D; Summerfelt A; Gold J; Buchanan RW
    Schizophr Bull; 2006 Oct; 32(4):692-700. PubMed ID: 16469942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.
    Griffith JM; O'Neill JE; Petty F; Garver D; Young D; Freedman R
    Biol Psychiatry; 1998 Jul; 44(2):98-106. PubMed ID: 9646891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron improves deficits in auditory P50 suppression in schizophrenia.
    Koike K; Hashimoto K; Takai N; Shimizu E; Komatsu N; Watanabe H; Nakazato M; Okamura N; Stevens KE; Freedman R; Iyo M
    Schizophr Res; 2005 Jul; 76(1):67-72. PubMed ID: 15927799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics.
    Adler LE; Hoffer LJ; Griffith J; Waldo MC; Freedman R
    Biol Psychiatry; 1992 Oct; 32(7):607-16. PubMed ID: 1450287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
    Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
    Martin LF; Kem WR; Freedman R
    Psychopharmacology (Berl); 2004 Jun; 174(1):54-64. PubMed ID: 15205879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
    Light GA; Geyer MA; Clementz BA; Cadenhead KS; Braff DL
    Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder.
    Cadenhead KS; Light GA; Geyer MA; Braff DL
    Am J Psychiatry; 2000 Jan; 157(1):55-9. PubMed ID: 10618013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateralization of auditory sensory gating and neuropsychological dysfunction in schizophrenia.
    Thoma RJ; Hanlon FM; Moses SN; Edgar JC; Huang M; Weisend MP; Irwin J; Sherwood A; Paulson K; Bustillo J; Adler LE; Miller GA; Cañive JM
    Am J Psychiatry; 2003 Sep; 160(9):1595-605. PubMed ID: 12944333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved p50 auditory gating with ondansetron in medicated schizophrenia patients.
    Adler LE; Cawthra EM; Donovan KA; Harris JG; Nagamoto HT; Olincy A; Waldo MC
    Am J Psychiatry; 2005 Feb; 162(2):386-8. PubMed ID: 15677607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
    Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
    Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P50 gating at acute and post-acute phases of first-episode schizophrenia.
    Devrim-Uçok M; Keskin-Ergen HY; Uçok A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia.
    Brockhaus-Dumke A; Mueller R; Faigle U; Klosterkoetter J
    Schizophr Res; 2008 Feb; 99(1-3):238-49. PubMed ID: 18160261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P50 gating in deficit and nondeficit schizophrenia.
    Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
    Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism.
    Knott V; Millar A; Fisher D; Albert P
    Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type.
    Martin LF; Leonard S; Hall MH; Tregellas JR; Freedman R; Olincy A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):611-4. PubMed ID: 17192894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal p50 gating in unmedicated schizophrenia outpatients.
    Arnfred SM; Chen AC; Glenthøj BY; Hemmingsen RP
    Am J Psychiatry; 2003 Dec; 160(12):2236-8. PubMed ID: 14638598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia, sensory gating, and nicotinic receptors.
    Adler LE; Olincy A; Waldo M; Harris JG; Griffith J; Stevens K; Flach K; Nagamoto H; Bickford P; Leonard S; Freedman R
    Schizophr Bull; 1998; 24(2):189-202. PubMed ID: 9613620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.